Targeting the Microenvironment in Acute Myeloid Leukemia

Armin Rashidi, Geoffrey L. Uy

Research output: Contribution to journalReview articlepeer-review

54 Scopus citations


The bone marrow microenvironment plays a critical role in the development, progression, and relapse of acute myeloid leukemia (AML). Similar to normal hematopoietic stem cells, AML blasts express receptors on their surface, allowing them to interact with specific components of the marrow microenvironment. These interactions contribute to both chemotherapy resistance and disease relapse. Preclinical studies and early phase clinical trials have demonstrated the potential for targeting the tumor-microenvironment interactions in AML. Agents currently under investigation include hypoxia-inducible agents and inhibitors of CXCR4 and adhesion molecules such as VLA-4 and E-selectin.

Original languageEnglish
Pages (from-to)126-131
Number of pages6
JournalCurrent Hematologic Malignancy Reports
Issue number2
StatePublished - Jun 28 2015


  • Leukemia
  • Mesenchymal
  • Microenvironment
  • Niche
  • Resistance
  • Stem cells


Dive into the research topics of 'Targeting the Microenvironment in Acute Myeloid Leukemia'. Together they form a unique fingerprint.

Cite this